Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 12.45
-0.08 (-0.64%)
Sep 4, 2026, 3:59 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 265.84 million as of September 4, 2026. Its market cap has increased by 128.46% in one year.
Market Cap
265.84M
Enterprise Value
178.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.45
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 265.84M, an increase of 351.87%. That is a compound annual growth rate of 34.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 265.84M | 117.13% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 963.72M |
| Eupraxia Pharmaceuticals | 591.18M |
| Helix BioPharma | 136.72M |
| Eastwood Bio-Medical Canada | 130.19M |
| ME Therapeutics Holdings | 75.97M |
| NurExone Biologic | 54.95M |
| MedMira | 49.12M |
| Telescope Innovations | 44.46M |